METROPOLIS - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 3.8
✅ Positive
Metropolis Healthcare is reporting strong revenue growth and increased profitability in FY26, evidenced by projected ₹1,646 Cr revenue and ₹191 Cr profit. The company’s solid financials, including a healthy ROCE of 15.9% and ROE of 12.2%, contribute positively to its outlook.
⚠️ Limitation
Despite the promising revenue forecast, the high P/E ratio of 75.1 suggests potential overvaluation, and the negative DII holding (-0.68%) indicates a lack of investor confidence within domestic institutions. The PEG ratio of 15.2 also raises concerns about valuation relative to earnings growth.
📉 Company Negative News
Recent news highlights a projected ₹1,646 Cr revenue and ₹191 Cr profit in FY26, signaling substantial growth but the Whalesbook article mentions a 31% increase in profits, suggesting potential discrepancies between projections and actual performance that could impact investor sentiment. Another news source indicates an optimistic outlook for share price increases.
📈 Company Positive News
None found
🏭 Industry
The healthcare sector is currently experiencing robust demand driven by increasing healthcare expenditure and rising disposable incomes globally. Metropolis Healthcare operates within this growing market, benefiting from the trend towards specialized medical services and hospital infrastructure development.
🧾 Conclusion
Based on the chart patterns, the stock appears to be in an upward trending phase, supported by a rising 50 DMA (551 ₹) above the 200 DMA (509 ₹). An entry zone could be established between 575-580 ₹, utilizing the recent support level. A potential exit zone would be at resistance around 600 - 605 ₹, providing a reasonable risk/reward ratio. Overall, the bullish technical indicators and strong revenue projections suggest a cautiously optimistic outlook for Metropolis Healthcare.